We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Radiation, Nanoparticles May Slow Alzheimer's

By HospiMedica staff writers
Posted on 25 Jan 2006
Researchers have discovered a new approach that uses gold nanoparticles to destroy beta-amyloid fibrils and plaque, believed to contribute to the mental deterioration of Alzheimer's patients. More...


The researchers state that the new technique, which they call a type of "molecular surgery,” could stop or slow the disease's progression without injuring healthy brain cells. The study was published in the January 11, 2006, issue of the American Chemical Society's journal Nano Letters.

Utilizing laboratory model studies, the investigators attached gold nanoparticles to a group of beta amyloid fibrils, incubated the ensuing compound for several days, and then exposed it to weak microwave fields for several hours. The energy levels of the fields were six times smaller than those of traditional cell phones and not likely to harm healthy cells, according to the researchers. The fibrils then dissolved and remained dissolved for at least one week after being irradiated, indicating that the treatment was not only successful at breaking up the fibrils but also resulted in a lower propensity of the proteins to re-aggregate, according to the researchers.

The same application also has potential for treating other neurodegenerative disorders that involve protein aggregation, including Parkinson's and Huntington's diseases, according to study leader Dr. Marcelo J. Kogan, from the University of Chile (Santiago). He reported that the application is similar to that of another investigational method that utilizes metallic nanoparticles to label and destroy cancer cells. Animal studies are planned, according to Dr. Kogan.


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.